New evidence pyramid

M Hassan Murad, Noor Asi, Mouaz Alsawas, Fares Alahdab

10.1136/ebmed-2016-110401

June 23, 2016

Reflections on using non-inferiority randomised placebo controlled trials in assessing cardiovascular safety of new agents for treatment of type 2 diabetes

Denise Campbell-Scherer

10.1136/ebmed-2017-110685

March 8, 2017

Editor's choice

Rating the certainty in evidence in the absence of a single estimate of effect

M Hassan Murad, Reem A Mustafa, Holger J Schünemann, Shahnaz Sultan, Nancy Santesso

10.1136/ebmed-2017-110668

March 20, 2017

Evidence-based medicine: a persisting desire under fire

Fares Alahdab, Samer Alabed, Ahmed Al-Moujahed, Mohammad Anass Al Sallakh, Tareq Alyousef, Ubai Alsharif, Munes Fares, M Hassan Murad

10.1136/ebmed-2016-110608

December 13, 2016

Editor's choice

Grading the quality of evidence in complex interventions: a guide for evidence-based practitioners

M Hassan Murad, Jehad Almasri, Mouaz Alsawas, Wigdan Farah

10.1136/ebmed-2016-110577

December 8, 2016

Editor's choice

EBHC pyramid 5.0 for accessing preappraised evidence and guidance

Brian S Alper, R Brian Haynes

10.1136/ebmed-2016-110447

June 20, 2016

Editor's choice

Semaglutide is non-inferior to placebo for cardiovascular outcomes in patients with type 2 diabetes

Denise Campbell-Scherer

10.1136/ebmed-2016-110652

March 7, 2017

Editor's choice

Practising evidence-based medicine (EBM): a descriptive analysis of medical students’ whole-task EBM assignments

Lauren A Maggio, Nicole Capdarest-Arest

10.1136/ebmed-2016-110593

February 6, 2017

Are eponyms used correctly or not? A literature review with a focus on shoulder and elbow surgery

Matthijs Paul Somford, Rebecca A Nieuwe Weme, Cornelis Niek van Dijk, Frank FA IJpma, Denise Eygendaal

10.1136/ebmed-2016-110453

August 26, 2016

Editor's choice

Cholesterol paradox: a correlate does not a surrogate make

Robert DuBroff

10.1136/ebmed-2016-110602

December 20, 2016